Literature DB >> 15809912

Burden of community-onset Escherichia coli bacteremia in seniors.

Lisa A Jackson1, Patti Benson, Kathleen M Neuzil, Marcus Grandjean, Jennifer L Marino.   

Abstract

BACKGROUND: Although Escherichia coli is a well-recognized cause of urinary tract infection in seniors, little is known about the burden of invasive E. coli infection in this population.
METHODS: We conducted a population-based cohort study of 46,238 noninstitutionalized Group Health Cooperative members>or=65 years of age to ascertain incidences of community-onset E. coli bacteremia and, for comparison, pneumococcal bacteremia, and we then performed a case-control study to identify risk factors for community-onset E. coli bacteremia.
RESULTS: The overall rate of community-onset E. coli bacteremia in the study cohort was 150 cases/100,000 person-years, which was approximately 3 times higher than the rate of pneumococcal bacteremia. In the case-control study, urinary catheterization and urinary incontinence were the only factors associated with an increased risk of E. coli bacteremia in men (62 cases), whereas cancer, renal failure, congestive heart failure, coronary artery disease, and urinary incontinence were associated with an increased risk of E. coli bacteremia in women (119 cases).
CONCLUSIONS: E. coli appears to be the leading cause of community-onset bacteremia in seniors, and, on the basis of these rates, we estimate that 53,476 cases occur in noninstitutionalized seniors each year in the United States. Community-onset E. coli bacteremia in seniors is, therefore, an infection of public health importance.

Entities:  

Mesh:

Year:  2005        PMID: 15809912     DOI: 10.1086/429344

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Underlying mechanism of in vivo and in vitro activity of C-terminal-amidated thanatin against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli.

Authors:  Zheng Hou; Jun Lu; Chao Fang; Ying Zhou; Hui Bai; Xiaogong Zhang; Xiaoyan Xue; Yingying Chen; Xiaoxing Luo
Journal:  J Infect Dis       Date:  2010-12-09       Impact factor: 5.226

2.  Hyperglucosuria induced by dapagliflozin augments bacterial colonization in the murine urinary tract.

Authors:  Panatda Saenkham; Jamie Jennings-Gee; Braden Hanson; Nancy D Kock; L Garry Adams; Sargurunathan Subashchandrabose
Journal:  Diabetes Obes Metab       Date:  2020-05-18       Impact factor: 6.577

3.  Burden of community-onset bloodstream infection: a population-based assessment.

Authors:  K B Laupland; D B Gregson; W W Flemons; D Hawkins; T Ross; D L Church
Journal:  Epidemiol Infect       Date:  2006-12-07       Impact factor: 2.451

4.  Characteristics of biofilms from urinary tract catheters and presence of biofilm-related components in Escherichia coli.

Authors:  Xiaoda Wang; Heinrich Lünsdorf; Ingrid Ehrén; Annelie Brauner; Ute Römling
Journal:  Curr Microbiol       Date:  2009-12-13       Impact factor: 2.188

Review 5.  Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?

Authors:  Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2014-08       Impact factor: 10.793

Review 6.  Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trends.

Authors:  Melha Mellata
Journal:  Foodborne Pathog Dis       Date:  2013-08-20       Impact factor: 3.171

7.  Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.

Authors:  Majdi N Al-Hasan; Brian D Lahr; Jeanette E Eckel-Passow; Larry M Baddour
Journal:  J Antimicrob Chemother       Date:  2009-05-12       Impact factor: 5.790

8.  A genomic island of an extraintestinal pathogenic Escherichia coli Strain enables the metabolism of fructooligosaccharides, which improves intestinal colonization.

Authors:  Catherine Schouler; Ahmed Taki; Iman Chouikha; Maryvonne Moulin-Schouleur; Philippe Gilot
Journal:  J Bacteriol       Date:  2008-10-31       Impact factor: 3.490

9.  Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis.

Authors:  Melha Mellata; Natalie M Mitchell; Florian Schödel; Roy Curtiss; Gerald B Pier
Journal:  Vaccine       Date:  2015-12-18       Impact factor: 3.641

10.  Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota.

Authors:  Sanjeev K Swami; Juliette T Liesinger; Nilay Shah; Larry M Baddour; Ritu Banerjee
Journal:  Mayo Clin Proc       Date:  2012-07-13       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.